Clinical Trial Update: A Study of Distal Jejunal-release Dextrose in Obese Participants [Phase 2]

View source ↗

Summary

Aphaia Pharma US LLC is conducting a Phase 2 trial of a distal jejunal-release dextrose formulation for obesity; the study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Distal Jejunal-release Dextrose (dextrose)

Snippet

Sponsor: Aphaia Pharma US LLC | Conditions: Obese | Phase 2 | Status: ACTIVE_NOT_RECRUITING